PEPE, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.756
EU - Europa 964
AS - Asia 690
SA - Sud America 61
AF - Africa 30
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.508
Nazione #
US - Stati Uniti d'America 1.729
SG - Singapore 360
UA - Ucraina 283
IT - Italia 204
HK - Hong Kong 166
CN - Cina 141
FI - Finlandia 96
DE - Germania 91
RU - Federazione Russa 82
NL - Olanda 72
IE - Irlanda 59
BR - Brasile 57
SE - Svezia 31
GB - Regno Unito 30
CI - Costa d'Avorio 28
CA - Canada 26
VN - Vietnam 9
FR - Francia 7
IN - India 6
AU - Australia 4
LT - Lituania 4
EU - Europa 3
TR - Turchia 3
CH - Svizzera 2
GE - Georgia 2
AR - Argentina 1
BD - Bangladesh 1
BE - Belgio 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
JO - Giordania 1
MA - Marocco 1
MX - Messico 1
RS - Serbia 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 3.508
Città #
Jacksonville 263
Woodbridge 231
Singapore 193
Chandler 184
Hong Kong 166
Millbury 115
Ashburn 78
Princeton 76
Ann Arbor 74
Amsterdam 67
Santa Clara 67
Wilmington 44
Houston 43
Nanjing 32
Beijing 30
Seattle 23
Ottawa 22
Milan 20
Helsinki 19
Boston 15
Shenyang 15
Cagliari 12
Falkenstein 11
Nanchang 11
Naples 10
Norwalk 10
Orange 10
Napoli 9
Dong Ket 8
Rome 8
Washington 8
Boardman 7
Hebei 7
Casoria 6
Falls Church 5
Indiana 5
Kronberg 5
Kunming 5
Munich 5
Castellammare di Stabia 4
Des Moines 4
Frankfurt am Main 4
Jiaxing 4
Lawrence 4
London 4
Los Angeles 4
Pune 4
Sydney 4
The Dalles 4
Toronto 4
Catania 3
Dublin 3
New York 3
Redmond 3
Shanghai 3
Tianjin 3
Turin 3
Zhengzhou 3
Ancona 2
Angra dos Reis 2
Avellino 2
Bareggio 2
Belo Horizonte 2
Changsha 2
Florence 2
Heidelberg 2
Kolkata 2
Mountain View 2
Parnamirim 2
Perugia 2
Pozzallo 2
Rapolla 2
Salvador 2
San Francisco 2
Springfield 2
Tbilisi 2
Vitória 2
Walnut 2
Zurich 2
Amman 1
Andover 1
Antalya 1
Armavir 1
Arroio Grande 1
Augusta 1
Bagé 1
Balneário Camboriú 1
Barra Mansa 1
Belgrade 1
Birigui 1
Bologna 1
Bonate Sopra 1
Brussels 1
Carangola 1
Cariacica 1
Casablanca 1
Cassilândia 1
Castelnuovo Rangone 1
Castelvetrano 1
Catalão 1
Totale 2.050
Nome #
Manuale di Oncologia Clinica 111
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-a genes on in vitro transformation of human mammary epithelial cells. 76
Società Italiana di Citofluorimetria (GIC) 75
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 73
Critical role of both p27kip1 and p21cip1/waf1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. 71
Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. 63
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 59
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors. 57
DNA index of ovarian carcinomas from 56 different patients: in vivo, in vitro studies. 57
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells. 57
Enzastaurin inhibits tumors sensitive and resistant to anti-EGFR drugs 56
Breast cancer prevention with fenretinide in young women at gentic and familial risk. A phase III randomized clinical trial 56
BRAF is a therapeutic target in aggressive thyroid carcinoma. 55
Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide. 54
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling 54
Phorbol-12-myristate-13-acetate (PMA) induces resistance of human melanoma cells to NK and LAK-mediated cytotoxicity. 52
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 52
In vitro and in vivo cytotoxicity of possible uracil metabolites of methylxanthines. 52
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture. 52
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. 52
Mitozolomide activity on human cancer cells "in vitro". 51
Epidermal growth factor (EGFR) and Transferrin (TRFR) receptor upregulation is induced by arabinoside cytosine (ARA-C) on human tumor cells. 51
Antisense-protein kinase A: a single-gene-based therapeutic approach. 51
Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells. 51
The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer. 51
Malignant melanoma Clustering with some familial/hereditary tumors 51
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the b1 integrin profile of cultured human tumor cells. 50
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway death is antagonized by epidermal growth factor. 49
Recombinant IFN-alfa 2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells. 49
cAMP-dependent protein kinase: role in normal and malignant growth. 49
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells. 49
Flow cytometric analysis of DNA content in human ovarian cancer. 48
Markers of cell proliferation as prognostic factors in differentiated thyroid cancer. 48
Retrospective Analysis of Familial Clustering for Malignant Melanoma 48
Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. 47
Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54p53wt and U251p53mut glioblastoma cell lines. 46
p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. 46
Quality control for the evaluation of the S-phase fraction by flow cytometry: a multicentric study. 45
NM23 gene expression correlates with cell growth rate and S-phase. 45
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study. 45
The cancer spectrum related to hereditary and familial breast and ovarian cancers 45
Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. 44
Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. 44
Synergistic anti-tumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells. 43
Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment. 43
Hereditary and familial breast and ovarian cancer: spectrum of related tumors. 43
In vitro cytotoxicity of VP-16213 on human ovarian cancer. 42
Overexpression of wild-type p53 ovverrides the mitogenic effect of the RIa subunit of protein kinase A in human breast cells. 42
Loss of thyrotropin regulation and trasforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells. 42
Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting Protein Kinase A in combination with docetaxel and anti-EGFR-Receptor antibody on human breast cancer cell growth. 42
TGFb inhibits rat thyroid cell proliferation without alterations in the expression of THS-induced cell cycle-related genes. Vol :pp , 41
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype 41
EGF activates an inducible survival response via the RAS -> Erk-1/2 pathway to counteract interferon-alfa-mediated apoptosis in epidermoid cancer cells. 41
Regulation of the expression of the low-affinity IgE receptor (FceRII) in the human monocyte-like cell line U-937 by phorbol esters and IgE. 40
Correlation between bevacizumab-related hypertension and response in mCRC patients 39
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-A in head and neck cancer cells in vitro and in vivo 38
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells. 38
Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells. 37
A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck. 36
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 36
Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective EGFR-tyrosine kinase inhibitor ZD1839 (‘Iressa’) 35
Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A. 34
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase C beta inhibitor, in non-small cell lung cancer cells. 34
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up. 32
Studio osservazionale sorveglianza diagnostica di donne ad alto rischio genetico-familiare di tumore mammario (ISSIN-HIBCR) 32
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014 31
Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents. 30
POLY (ADP-RIBOSE) POLYMERASE (PARP-1) EXPRESSION IN MALIGNANT MELANOMAS FROM PHOTO EXPOSED AREAS OF THE HEAD AND NECK REGION 30
8-Chloro-cAMP enhances the growth inhibitory effect of cytotoxic drugs in human colon cancer cells 29
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 29
Differential sensitivity to non-MHC-restricted rIL-2 activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or PKA subunits. 28
The cAMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. 27
Fine needle cytology, infectious diseases and non-Hodgkin lymphoma 27
null 26
New biomolecular prognostic and predictive factors of response to treatments in colorectal cancer 26
Phase I clinical study with 8-Chloro-cAMP and evaluation of immunological effects in cancer patients. 25
Le neoplasie eredo-familiari della mammella, dell'ovaio e del colon retto. Aspetti clininci, diagnostici e teraputici. 25
Differential effects of type I and type II protein kinase A isoforms on chinese hamster ovary cell cycle and proliferation. 23
The RIalfa subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. 19
Retroviral vector-mediated overexpression of the RIIbeta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts. 19
TSH-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cAMP-dependent protein kinase 15
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategies 10
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27. 6
Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study 6
Totale 3.619
Categoria #
all - tutte 15.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020116 0 0 0 0 0 0 0 0 0 18 25 73
2020/2021479 4 54 59 58 57 53 60 2 61 4 53 14
2021/2022434 8 1 2 1 2 23 3 17 61 42 112 162
2022/2023469 85 41 14 18 49 54 7 33 59 71 34 4
2023/2024423 13 61 29 44 28 47 10 82 0 11 66 32
2024/2025880 96 105 12 18 46 96 264 153 90 0 0 0
Totale 3.619